Mylan, like other generic drugmakers, feels the pricing pain

Mylan, like other generic drugmakers, feels the pricing pain


This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan reports earnings Wednesday, Aug. 9, 2017.



from Biotech News